GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Weiguang Biological Products Co Ltd (SZSE:002880) » Definitions » Total Equity

Shenzhen Weiguang Biological Products Co (SZSE:002880) Total Equity : ¥2,092 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Weiguang Biological Products Co Total Equity?

Shenzhen Weiguang Biological Products Co's total equity for the quarter that ended in Mar. 2024 was ¥2,092 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Shenzhen Weiguang Biological Products Co Total Equity Historical Data

The historical data trend for Shenzhen Weiguang Biological Products Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Weiguang Biological Products Co Total Equity Chart

Shenzhen Weiguang Biological Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,448.76 1,623.78 1,788.28 1,867.76 2,045.64

Shenzhen Weiguang Biological Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,913.16 1,968.42 1,973.52 2,045.64 2,092.43

Shenzhen Weiguang Biological Products Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shenzhen Weiguang Biological Products Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=2876.779-831.14
=2,046

Shenzhen Weiguang Biological Products Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=3033.262-940.83
=2,092

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Weiguang Biological Products Co Total Equity Related Terms

Thank you for viewing the detailed overview of Shenzhen Weiguang Biological Products Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Weiguang Biological Products Co (SZSE:002880) Business Description

Traded in Other Exchanges
N/A
Address
Guangming Street, No. 3402, Guangqiao Avenue, Guangming New District, Guangdong Province, Guangming, CHN, 518107
Shenzhen Weiguang Biological Products Co Ltd is the pharmaceutical company. It is mainly engaged in the research and development, production and sales of blood products. The company's products portfolio includes human albumin, intravenous immunoglobulin (pH4), lyophilized human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, tetanus Human immunoglobulin, histamine human immunoglobulin, human fibrinogen, a total of 21 varieties of 21 specifications.
Executives
Guo Cai Ping Executives

Shenzhen Weiguang Biological Products Co (SZSE:002880) Headlines

No Headlines